# Ascenta Therapeutics, Inc. — Form D

Ascenta Therapeutics, Inc. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-05. The offering totals $15.0M, of which $1.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-02-05
- Form: D
- Accession: 0001483471-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.0M
- Amount sold: $1.8M
- Remaining: $13.2M
- Investors: 12
- Date of first sale: 2010-01-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-138499

## Issuer

- Name: Ascenta Therapeutics, Inc.
- CIK: 0001483471
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 101 LINDENWOOD DRIVE, SUITE 405, MALVERN, PA, 19355
- Phone: 610-408-0301

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Louis Bock | Director | Georgetown, TX |
| Marc Lippman | Director | Boston, MA |
| Michael Powell | Director | Cambridge, MA |
| Norman Selby | Director | New York, NY |
| Andrew E Senyei | Director | San Diego, CA |
| J. Mel Sorensen | Director | Malvern, PA |
| Joel Sussman | Director | Malvern, PA |
| Eckard E Weber | Director | San Diego, CA |
| Michael Powell | Executive Officer | Cambridge, MA |
| J. Mel Sorensen | Executive Officer | Malvern, PA |
| Joel Sussman | Executive Officer | Malvern, PA |

## More

- [CIK 1483471 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1483471&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001483471-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.